Correction: Qamar et al. Treatment of Peripheral Artery Disease Using Injectable Biomaterials and Drug-Coated Balloons: Safety and Efficacy Perspective. Pharmaceutics 2023, 15, 1813
- -
- Section 4, Subsection 4.1.1, through the removal of “One of the studies has shown that NanoPac is responsible for inducing tumor in an in vivo model [37], while another study has provided the detail on its pharmacokinetics profile [38] and ability to reduce tumor regression [39]” and the removal of references 37, 38, and 39;
- -
- Table 2, Column “Outcome”, through the removal of “lower percentage area stenosis; improved neointimal proliferation and reduced tumor regression” and the addition of “more studies needed to be carried out for assessing the actual potential”.
Reference
- Qamar, S.U.R.; Spahić, L.; Benolić, L.; Zivanovic, M.; Filipović, N. Treatment of Peripheral Artery Disease Using Injectable Biomaterials and Drug-Coated Balloons: Safety and Efficacy Perspective. Pharmaceutics 2023, 15, 1813. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Qamar, S.U.R.; Spahić, L.; Benolić, L.; Zivanovic, M.; Filipović, N. Correction: Qamar et al. Treatment of Peripheral Artery Disease Using Injectable Biomaterials and Drug-Coated Balloons: Safety and Efficacy Perspective. Pharmaceutics 2023, 15, 1813. Pharmaceutics 2023, 15, 2555. https://doi.org/10.3390/pharmaceutics15112555
Qamar SUR, Spahić L, Benolić L, Zivanovic M, Filipović N. Correction: Qamar et al. Treatment of Peripheral Artery Disease Using Injectable Biomaterials and Drug-Coated Balloons: Safety and Efficacy Perspective. Pharmaceutics 2023, 15, 1813. Pharmaceutics. 2023; 15(11):2555. https://doi.org/10.3390/pharmaceutics15112555
Chicago/Turabian StyleQamar, Safi Ur Rehman, Lemana Spahić, Leo Benolić, Marko Zivanovic, and Nenad Filipović. 2023. "Correction: Qamar et al. Treatment of Peripheral Artery Disease Using Injectable Biomaterials and Drug-Coated Balloons: Safety and Efficacy Perspective. Pharmaceutics 2023, 15, 1813" Pharmaceutics 15, no. 11: 2555. https://doi.org/10.3390/pharmaceutics15112555
APA StyleQamar, S. U. R., Spahić, L., Benolić, L., Zivanovic, M., & Filipović, N. (2023). Correction: Qamar et al. Treatment of Peripheral Artery Disease Using Injectable Biomaterials and Drug-Coated Balloons: Safety and Efficacy Perspective. Pharmaceutics 2023, 15, 1813. Pharmaceutics, 15(11), 2555. https://doi.org/10.3390/pharmaceutics15112555